| | | | | | | | | | |
|
| |
|
| Dockets Entered
On September 6, 2006
Table of Contents
|
|
|
|
|
|
|
|
|
|
|
| Docket #
|
| Title
|
|
|
|
|
|
|
| 2006E-0366
|
| Patent Extension Application for Decapinol Oral Rinse, U.S. Patent No. 4,894,221
|
|
|
|
|
| 2006N-0185
|
| Agency Information Collection Activities; Proposed Collection; Comment Request; Guidance on Informed Consent for In Vitro Diagnostic Device Studies Using Leftover Human Specimens That Are Not Individu
|
|
|
|
|
|
| 2006P-0351
|
| Restriction or withdrawal of the use of angiotensin converting enzyme inhibitor (ACEI) and angiotensin receptor blocker (ARB) therapy in the following conditions
|
|
| |
|
| 2006E-0366
|
| Patent Extension Application for Decapinol Oral Rinse, U.S. Patent No. 4,894,221
|
|
|
|
|
| APP 1
|
| Sinclair Pharma AB
|
| Vol #:
|
| 1
|
|
|
|
|
| LET 1
|
| U.S. Patent and Trademark Office to FDA/Office of Regulatory Policy
|
| Vol #:
|
| 3
|
|
|
|
|
| LET 2
|
| U.S. Patent and Trademark Office to Marshall, Gerstein & Borun, LLP
|
| Vol #:
|
| 3
|
|
|
|
|
| LET 3
|
| Sinclair Pharmaceuticals Limited
|
| Vol #:
|
| 3
|
|
|
|
|
| 2006N-0185
|
| Agency Information Collection Activities; Proposed Collection; Comment Request; Guidance on Informed Consent for In Vitro Diagnostic Device Studies Using Leftover Human Specimens That Are Not Individu
|
|
|
|
|
|
|
|
|
| N 2
|
| FDA
|
| Vol #:
|
| 1
|
|
|
|
|
| 2006P-0351
|
| Restriction or withdrawal of the use of angiotensin converting enzyme inhibitor (ACEI) and angiotensin receptor blocker (ARB) therapy in the following conditions
|
|
|
|
|
| ACK 1
|
| FDA/DDM Diplomate of the American Board of Internal Medicine & Nephrology Fulbright Scholar in
|
| Vol #:
|
| 1
|
|
|
|
|
| CP 1
|
| Diplomate of the American Board of Internal Medicine & Nephrology Fulbright Scholar in Medicine
|
| Vol #:
|
| 1
|
|
